Medicenna Therapeutics Corp experienced a notable uptick in its stock price, reflecting investor optimism.
In yesterday's trading session, Medicenna's stock rose by 6.10%, closing at CA$0.43. This increase shows a positive sentiment among investors, especially considering the company's recent announcements and ongoing developments.
Advertisement
Medicenna Therapeutics Corp
MDNA.TO
MDNA.TO
Medicenna Therapeutics Corp
WealthAwesomeMarket cap
$37.84M
52W high
$1.97
52W low
$0.34
1W change
-6.82%
Beta
2.10
Analyst Price Targets
Based on analyst covering MDNA · as of Sep 17, 2026
Wall Street analysts forecast MDNA stock price to rise 680.5% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$3.20
+680.5% Upside
Current Price
C$0.41
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MDNA's historical volatility
30-Day Vol
53.4%
Annualized
90-Day Vol
53.2%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$0.50
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.45 | C$0.37 – C$0.54 |
| 60 trading days | C$0.47 | C$0.36 – C$0.61 |
| 90 trading days | C$0.50 | C$0.36 – C$0.69 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors may see Medicenna's recent stock performance as a sign of growing confidence in its future, particularly with upcoming presentations and financial results.
Medicenna's Stock Climbs 6.10%
The 6.10% increase reflects heightened investor interest and confidence in Medicenna's strategic initiatives.
Bull case
The recent surge suggests that investors are reacting positively to Medicenna's upcoming presentations and financial results. This optimism points to a belief in the company's growth potential and strategic direction.
Bear case
Despite the positive movement, investors should be cautious. Medicenna's market cap is relatively small at CA$40.15 million, and its lack of profitability could pose risks if future developments don’t meet expectations.
Market Reaction to Medicenna's Performance
Advertisement
The 6.10% increase in Medicenna's stock price can be linked to positive investor sentiment about the company's future initiatives. With the announcement of its participation in the H.C. Wainwright 28th Annual Global Investment Conference, investors are eager to learn about potential advancements and strategic plans.
Upcoming Financial Results
Medicenna recently reported its first-quarter fiscal 2027 financial results, which may have boosted investor optimism. As the company prepares for more presentations and updates, stakeholders are closely watching how these developments could impact future performance. For more details, check out the latest updates on Medicenna's stock page.
Risks and Considerations
While the stock's rise is encouraging, investors should keep an eye on the company's current market cap of CA$40.15 million and its lack of profitability. As Medicenna moves forward, executing its strategies will be crucial for maintaining investor confidence. For further insights, visit Medicenna's stock page.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
